None listed
Conditions
Interventions
None listed
Sponsors
Myongji Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Female patients aged =19 years (2) Subjects to treat partial mastectomy or radical surgery of breast and axilla for diagnosis of breast cancer (3) Patients with breast cancer in stages 0-3 (4) Subjects who needed the using the Megaderm® before primary suture immediately after surgery. (5) Subject who can follow-up investigation
Exclusion criteria
Exclusion criteria: (1) 4th stage metastatic or inflammatory breast cancer patient (2) Patients with infectious diseases, autoimmune disease, and hemostatic disorder (3) Patients suspected of inflammatory infection in the breast before surgery (4) Pregnancy (5) Other, subjects deemed to be in difficulty with clinical research or not required to use Megaderm® by the judgment of the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective satisfaction score of the cosmetic outcomes | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical adverse event and oncology safety with the use of megaderm in surgery | — |
Countries
Korea, Republic of
Contacts
Public ContactHyuk-Jai Shin
Myongji Hospital
Outcome results
None listed